KeithDavidEatonMD

Associate Professor of Medicine, University Wash

Dr. Eaton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Ambulatory Clinic
825 Eastlake Avenue East
Seattle, WA 98109
Phone+1 206-288-1000

University of WashingtonFellowship, Hematology and Medical Oncology, 2001 - 2004
University of WashingtonResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998

PubMed

Phase 1/2 trial of XPO1 inhibitor selinexor plus docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer.
Mitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, Leora Horn, D Ross Camidge
Clinical Cancer Research. 2024-12-09
1 citations
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.
Lyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, Sanjay Goel, Rebecca Heist
Future Oncology. 2024-12-01
7 citations
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.
Joseph B Hiatt, Anna-Lisa Doebley, Henry U Arnold, Mohamed Adil, Holly Sandborg
Science Advances. 2024-04-12

ASCO Annual Meeting to Highlight Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA)May 21st, 2020
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per PatientOctober 17th, 2017